Summary:
- The article discusses the controversy surrounding the use of hydroxychloroquine as a treatment for COVID-19, particularly the claims that it caused thousands of deaths.
- It examines a study published in The Lancet in May 2020 that claimed hydroxychloroquine was associated with increased mortality in COVID-19 patients, which led to the suspension of clinical trials and widespread rejection of the drug as a treatment.
- The article argues that the Lancet study was flawed and that the claim of 17,000 deaths due to hydroxychloroquine was never substantiated, highlighting the need for more rigorous scientific scrutiny and transparency in the evaluation of potential COVID-19 treatments.